Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 15, 2022 - Issue
Submit an article Journal homepage
190
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Interleukin-17A Inhibitor Secukinumab Treatment in HIV-Positive Psoriasis Patient: A Case Report

Jian Gong1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5175-9146View further author information
ORCID Icon,
Weiwei Wu3 Department of Plastic and Dermatological Surgery, The Fifth People’s Hospital of Hainan Province, Haikou, Hainan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5029-6936View further author information
ORCID Icon,
Liguo Qiu1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaView further author information
,
Xi Wang1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaView further author information
,
Jianwei Bao1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaView further author information
,
Jinjing Wang4 Clinical School of Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, People’s Republic of ChinaView further author information
,
Lifang Cheng1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaView further author information
,
Zhiyuan Fu1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;5 Department of Pharmacy, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Fengming Hu1 Department of Integrated Traditional Chinese and Western Medicine of Dermatology, Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, People’s Republic of China;2 Jiangxi Provincial Clinical Research Center for Skin Diseases, Nanchang, Jiangxi, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3951-3666View further author information
ORCID Icon show all
Pages 2949-2956 | Received 10 Nov 2022, Accepted 23 Dec 2022, Published online: 30 Dec 2022

References

  • Daniyal M, Akram M, Zainab R, et al. Progress and prospects in the management of psoriasis and developments in phyto-therapeutic modalities. Dermatol Ther. 2019;32:e12866. doi:10.1111/dth.12866
  • World Health Organization. WHO HIV update: global epidemic and progress in scale up and policy uptake [EB/OL]; [about 1 screen]. Geneva: World Health Organization; 2022. Available from: http://www.who.int/hiv/data/en/. Accessed December 27, 2022.
  • Mallon E, Bunker CB. HIV-associated psoriasis. AIDS Patient Care STDs. 2000;14:239–246. doi:10.1089/108729100317696
  • Muñoz-Pérez MA, Rodriguez-Pichardo A, Camacho F. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3-year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol. 1998;139:33–39. doi:10.1046/j.1365-2133.1998.02310.x
  • Yen YF, Jen IA, Chen M, et al. HIV infection increases the risk of incident psoriasis: a nationwide population-based cohort study in Taiwan. J Acquir Immune Defic Syndr. 2017;75:493–499. doi:10.1097/QAI.0000000000001431
  • Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010;10:470–478. doi:10.1016/S1473-3099(10)70101-8
  • Johnson TM, Duvic M, Rapini RP, Rios A. AIDS exacerbates psoriasis. N Engl J Med. 1985;313:1415.
  • Ceccarelli M, Venanzi Rullo E, Vaccaro M, et al. HIV-associated psoriasis: epidemiology, pathogenesis, and management. Dermatol Ther. 2019;32:e12806. doi:10.1111/dth.12806
  • Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 1994;265:248–252. doi:10.1126/science.8023143
  • Clerici M, Shearer GM. The Th1–Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994;15:575–581. doi:10.1016/0167-5699(94)90220-8
  • Menon K, Van Voorhees AS, Bebo BF Jr, et al. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62:291–299. doi:10.1016/j.jaad.2009.03.047
  • Ochi SI, Hayashi M, Yamaoka T, et al. Occult HIV infection in Japanese rupioid psoriasis. J Dermatol. 2017;44:e172–e173. doi:10.1111/1346-8138.13850
  • Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et al. British Association Of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177:628–636. doi:10.1111/bjd.15665
  • Fink D, Hedley L, Miller R. Systematic review of the efficacy and safety of biological therapy for inflammatory conditions in HIV-infected individuals. Int J STD AIDS. 2017;28:110. doi:10.1177/0956462416675109
  • Ting PT, Koo JY. Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients. Int J Dermatol. 2006;45:689–692. doi:10.1111/j.1365-4632.2005.02642.x
  • Myers B, Thibodeaux Q, Reddy V, et al. Biologic treatment of 4 HIV-positive patients: a case series and literature review. J Psoriasis Psoriatic Arthritis. 2020;6:19–26. doi:10.1177/2475530320954279
  • Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD. The use of anti-tumor necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis. 2008;67:710–712. doi:10.1136/ard.2007.081513
  • Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029–1072. doi:10.1016/j.jaad.2018.11.057
  • Pangilinan MCG, Sermswan P, Asawanonda P. Use of anti-IL-17 monoclonal antibodies in HIV patients with erythrodermic psoriasis. Case Rep Dermatol. 2020;12:132–137. doi:10.1159/000508781
  • Vito DL, Casanova DM, Elisa G. Secukinumab in an HIV-positive patient with psoriasis. J Dtsch Dermatol Ges. 2019;17:646–668.
  • Bernardini N, Skroza N, Tolino E, et al. HIV positive patient treated with ixekizumab. Clin Ter. 2022;173:195–197. doi:10.7417/CT.2022.2416
  • Qin H, Lu J, Yi X, Ding Y, Shi Y. Secukinumab treatment for a psoriasis patient co-infected with HIV and latent tuberculosis: a case report. J Dermatol. 2022. doi:10.1111/1346-8138.16494
  • Nakamura M, Abrouk M, Farahnik B, Zhu TH, Bhutani T. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies. Cutis. 2018;101(1):38;42;56.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.